The synthesis, base pairing properties and in vitro (polymerase) and in vivo (E. coli) recognition of 2'-deoxynucleotides with a 2-amino-6-methyl-8-oxo-7,8-dihydro-purine (X), a 2-methyl-6-thiopurine (Y) and a 6-methyl-4-pyrimidone (Z) base moiety are described. As demonstrated by Tm measurements, the X and Y bases fail to form a self-complementary base pair. Despite this failure, enzymatic incorporation experiments show that selected DNA polymerases recognize the X nucleotide and incorporate this modified nucleotide versus X in the template. In vivo, X is mainly recognized as a A/G or C base; Y is recognized as a G or C base and Z is mostly recognized as T or C. Replacing functional groups in nucleobases normally involved in W-C recognition (6-carbonyl and 2-amino group of purine; 6-carbonyl of pyrimidine) readily leads to orthogonality (absence of base pairing with natural bases).
Introduction
Expanding the genetic alphabet to include an additional base pair has led to the replication of such a base pair in a bacterial cell, [1] and in the use of such a base pair to code for unnatural amino acids. [2] Numerous research groups have studied base modified nucleic acids but few of them have been evaluated in vivo. [2] [3] The candidate base pairs are comprised of reorganized donoracceptor hydrogen-bonding groups, [4] increased number of hydrogen bonds, [5] size expanded bases, [3b, 6] hydrophobic bases, [7] and metal-ion coordinating bases. [8] For example, the work of Hirao, [9] and Romesberg, [1] [2] demonstrates that hydrophobic interactions may contribute to stable base pairing. The work of Benner is an example how reorganization of donoraccepter interactions may lead to orthogonal base pairing in vitro.
[4c] But many others, likewise, contributed to this research field, [10] and this research has been the subject of many reviews. [11] Introduction of a methyl group in the 5-position of 2'-deoxyuridine (giving thymidine) and in the 5-position of 2'-deoxycytidine (giving 5-methyl-2'-deoxycytidine) increases duplex stability of double stranded nucleic acids due to hydrophobic interactions with the neighbouring bases.
[12] Here we have replaced functionalities of purine and pyrimidine bases, normally involved in base pairing, with a methyl group to investigate the influence on duplex stability and to investigate the potential to involve them in new base pairing systems. A second small hydrophobic functionality that is involved in this study is a thiocarbonyl group (replacing a carbonyl group), for its potential to interact with the methyl group present in opposite bases in a duplex. By introducing such methyl and thiocarbonyl group, we will make the major (or minor groove) more hydrophobic which may not be favourable for duplex stabilization and could contribute to orthogonality. However, there are several precedents of the involvement of a hydrophobic thiocarbonyl group in base pair stabilization and some natural t RNA contain sulphur modified nucleobases such as 2-thio-U, 4-thio-U, 2-thio-C. [13] Rappaport has studied the 6-thioguanine (GS): 5-methyl-2-pyrimidone (T H ) base pair ( Figure 1a) . [14] The laboratory of Switzer has investigated the 2-thio-isoguanine (iGS):5-methyl-isocytosine (iC Me ) base pair [15] (Figure 1b ) and the 2-thio-isoguanine(iGS):5-methyl-4-pyrimidone (P) [16] base pair ( Figure 1c ). In all these cases the thiocarbonyl group was placed opposite an NH 2 group or an H-atom and the stability of the base pair (G S 
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The use of a self-complementary base for the expansion of the genetic alphabet has the advantage that the potential for mispairing with the natural bases is reduced (as only one base has to be considered for mispairing). It is not really a limitation since the addition of a single self-complementary base to the genetic alphabet would create 61 new codons. For example Pochet and Marlière [17] proposed a self-pair using a 2-amino-8-oxo-7,8-dihydro-purine base, with the potential to form two hydrogen bonds (Figure 2a ). This work is based on the wellrecognized ability of the mutagenic 8-oxoguanine to base pair with adenine base, the former oriented in the syn conformation. This 8-oxoG (syn):A(anti) base pair was studied by X-ray diffraction and NMR [18] Replacement of G with 8-oxoG increases thermal stability of duplex when A is placed in the opposite position. [19] The presence of the 8-oxo group induces glycosidic bond rotation which led to 8-oxoG(syn):A(anti) conformation.
[18b] When 2-amino-8-oxo-7,8-dihydro-purine is placed opposite to A, thermal stability of the duplexes (compared with A:T) is decreased. [20] However, 2-amino-8-oxo-7,8-dihydro-purine:2-amino-8-oxo-7,8-dihydropurine self-pair showed less destabilization. The relative stability of the 2-amino-8-oxo-7,8-dihydro-purine self-pair could be explained by the formation of two hydrogen bonds (Figure 2a) . A first example that we investigated is the potential selfcomplimentary base pair 2-amino-6-methyl-8-oxo-7,8-dihydropurine (X) (Figure 2b Further, we have included in our study the 2-methyl-6-thiopurine base (Y) to pair with the 6-methyl-4-pyrimidone heterocycle ( Figure 1d ) (Z) and with itself ( Figure 1e ). In addition, potential pairing of the modified pyrimidone heterocycle (Z) with the previously mentioned 2-amino-6-methyl-8-oxo-7,8-dihydro-purine base (X) was investigated ( Figure 1f ). There are many precedents in the literature of the stabilization of macromolecular structure or small molecule interactions by thiocarbonyl and methyl groups. [21] In addition the higher polarizability of sulphur over oxygen may contribute to enhanced stacking interactions. [22] Our investigation started by building a static in silico model to analyse if X:X interactions and Z:Y interactions are potentially accessible in a dsDNA context. The models are shown in Figures 4 and 5. Although distances between functional groups are not optimal, closer contacts are possible in the pyrimidine:purine system ( Figure 5 ) than in the purine self-pair system (Figure 4) . The 6-methyl-4-pyrimidone nucleoside was modelled in the trans configuration, while the presence of the 4-carbonyl group would suggest that the cis configuration is more stable. The models demonstrate that, in theory, accommodation of both base pairs in a dsDNA structure might be possible. 
Result and discussion
The 2-chloro-4-amino-5-nitro-6-methyl pyrimidine 2 was synthesized according to a reported procedure with minor modifications. [23] The nitro group of 2 was reduced using sodium hydrosulphite to afford 2-chloro-4,5-diamino-6-methyl pyrimidine 3. Reaction of 2-chloro-4,5-diamino-6-methyl-pyrimidine 3 with 1,1'-carbonyldiimidazole in 1,4-dioxane at 110 °C afforded compound 4. The sodium salt of 4, produced in situ using NaH in acetonitrile was reacted with 1-chloro-2-deoxy-3,5-di-O-p-toluoyl-α-Derythro-pentofuranose at 50 °C. The reaction mixture was purified on silica gel column to afford 2-chloro-6-methyl-8-oxo-7,8-dihydro-9-(2-deoxy-3,5-di-O-p-toluoyl-D-erythro-pentofuranos-1-yl)-purine (5) as an inseparable mixture of α and β-anomer in 30% yield. Treatment of 5 with sodium methoxide in methanol deprotected the toluoyl groups. The crude product was then purified by flash column chromatography to yield an inseparable anomeric mixture of 6 as a white solid. Compound 6 was converted to its dimethoxytrityl derivative 7 by selective protection of the primary alcohol with 4,4'-dimethoxytrityl chloride (DMTrCl) in pyridine. Flash column chromatography was used to separate the desired β-isomer from the α-isomer and ROESY and HMBC of 2D NMR was used to prove the correct structure. Trityl deprotection of compound 7 afforded the nucleoside 8. 2D NMR analysis of compound 8 confirmed the previous structural analysis. However, amination of 2-chloro of compound 6 using ammonia under heating conditions was unsuccessful. Therefore, we decided to replace first the 2-chloro by a 2-azido group, and to separate the isomers after introduction of the 2-amino function. Thus, nucleoside 6 was treated with hydrazine in ethanol to afford the 2-hydrazino derivative 9 which on further reaction with nitrous acid at −5 °C, led to formation of 2-azido-6-methyl-8-oxo-7,8-dihydro-purine nucleoside 10. Reduction of azido group followed by N,N-dimethylaminomethylidene protection of the resulting amine function afforded compound 12 which, upon tritylation, gave a separable mixture of the α,β-anomers 13. The desired β-anomer was isolated by flash column chromatography and converted into phosphoramidite 14 by reaction with bis(diisopropylamino)(2-cyanoethoxy)phosphine in the presence of tetrazole. The triphosphate (of compound β-12) was synthesized according to the method described by Ludwig [24] starting from corresponding N,N-dimethylaminomethylidene protected nucleoside β-12 (obtained by detritylation of compound 13) (Scheme 3). In this procedure, regioselective phosphorylation of the 5'-hydroxy group of the sugar moiety was carried out with phosphoryl oxychloride in trimethyl phosphate followed by the addition of tetrabutylammonium pyrophosphate. The reaction product was deprotected with aqueous ammonia, isolated on Sephadex A25 column and final purification was performed by RP HPLC. As depicted in scheme 4, glycosylation of commercially available 6-methyl-4-pyrimidone with 3,5-bis-(toluoyl)-2-deoxyribosyl chloride using bis(trimethylsilyl)acetamide and SnCl 4 in dry acetonitrile afforded a crude mixture of 6-methyl-4-pyrimidone nucleoside. The cleavage of toluoyl-protecting group was carried out using 5 M solution of sodium methoxide in methanol to afford pure 6-methyl-3-(2-deoxy-β-D-erythro-pentofuranos-1-yl)-4-pyrimidone Z in 36% yield over two steps. Selective protection of the primary alcohol with 4,4'-dimethoxytrityl chloride (DMTrCl) in pyridine gave 16, which was then converted to phosphoramidite 17 by reaction with bis(diisopropylamino)(2-cyanoethoxy) phosphine in the presence of tetrazole. The sodium salt of 2-methyl-6-chloropurine, produced in situ using NaH in acetonitrile, was reacted with l-chloro-2-deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofuranose at room temperature to afford the desired nucleoside 18a in 76% yield (Scheme 5). The 6-chloro group in 18a was converted into a thiol group by treatment with sodium thiosulfate. Cleavage of toluoyl protecting groups by a 5 M solution of sodium methoxide in methanol (compound Y) followed by reaction with 3-bromopropionitrile in presence of potassium carbonate gave compound 19. Selective protection of the primary alcohol with 4,4'-dimethoxytrityl chloride (DMTrCl) in pyridine gave 20, which was then converted to its phosphoramidite 21 by reaction with bis(diisopropylamino) (2-cyanoethoxy)phosphine in the presence of tetrazole. 
Hybridization properties of XNA modified DNA
The oligonucleotides were synthesized by using the phosphoramidite method and the reagents 14, 17 and 21 on solid phase employing a DNA synthesizer. The synthesized sequences, together with the MS data, are shown in Table 1 . The oligonucleotides ON 20-23 were used as well for T m studies as for in vivo transliteration experiments.
Base pairing properties of the X, Y and Z bases were examined by hybridizing oligomers with their complementary strands and determining the T m of the hybrids by temperature-dependent UV spectroscopy. The T m was determined at 260 nm in NaCl (0.1M) buffer with KH 2 PO 4 (20 mM, pH 7.5) and EDTA (0.1 mM) at a concentration of 4 µM for each strand. The stability of the duplexes containing the modified bases (X, Y, Z) was compared to the stability of the natural DNA duplex (Table 2 ). In order to investigate the selectivity of base pairing, the stability of duplexes with modified X, Y, Z bases and the four canonical bases (A, T, G, C) was investigated by T m determination (Table  3) As the strength of duplex formation is not only the result of potential interstrand base:base interactions by H-bonding but also due to potential base:base interactions by interstrand stacking, we have evaluated the X:X and the Y:Z system further by incorporating several modified X, Y and Z bases in a dsDNA, either separately or consecutively (Table 4) . One of the sequences is phosphorylated at the 5'-position, because this sequence was also used for insertion in a plasmid for the in vivo experiments. The T m data shows that multiple incorporations further reduced duplex stability in comparison to dsDNA reference duplex (T m = 72.9 °C).
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Finally, we carried out three additional experiments to further analyze the properties of the 2-amino-6-methyl-8-oxo-7,8-dihydropurine (X) base: a) the potential of the X base to induce hairpin formation; b) a CD experiment to compare the shape of natural dsDNA with the "X incorporated" dsDNA; c) the potential of the triphosphate of the X nucleoside to function as substrate for DNA polymerases.
The 2-amino-6-methyl-8-oxo-7,8-dihydro-purine nucleosides X was incorporated in the self-complementary 5'-GCG CAT GCG-C-3' DNA sequence as well at the second position from both ends as in the middle positions and the T m was measured at different concentrations ranging from 2 µM to 12 µM in 1N NaCl at 286 nm (Table 5 ). When positioning X at both ends, the oligonucleotide remains in a self-complementary duplex just as the natural sequence, although with considerably reduced T m . However, positioning XX in the middle of the oligonucleotide, force it to adopt a hairpin conformation. This is in agreement with former observations that the X:X base pair is not really formed. The spectra shows a more narrow negative peak at 255 nm and positive peak at 276 nm with reduced height. The introduction of modified self-complementary base pair with hydrophobic groups not only destabilizes the DNA duplex but also results in small conformational changes. The enzymatic incorporation of the modified X nucleotides in DNA was tested using Klenow (exo -) and Pol6G12. The Klenow fragment was chosen because of its potential relevance for in vivo work in E. coli. The Pol6G12, an evolved enzyme derived from the thermophilic archaebacterium Thermococcus gorgonarius, was chosen because of its potential relevance for in vitro work (XNA gene synthesis and aptamer). First the triphosphate of the 2-amino-6-methyl-8-oxo-7,8-dihydro-9-(2-deoxy-β-D-erythropentofuranos-1-yl)-purine nucleoside was synthesized (15, Scheme 3). The incorporation of natural dNTP's and the modified nucleotide X was compared using a template with one and three nucleotides incorporated (see experimental section) and a DNA primer. Using Klenow polymerase in the absence of Mn 2+ little X is incorporated against X in the template (Figure 8 ). Using Klenow polymerase in the presence of Mn 2+ , the incorporation efficiency significantly increases (Figure 8 ). Data are similar for 50 µM and 200 µM of the modified nucleotide and using a template with one or three modified bases. In Figure 8 , only data with one modified base in the template is shown. Similar results are observed using Pol6G12. In the presence of Mn 2+ , the modified nucleotide X is incorporated against X in the template, although from previous experiments we know that X:X does not form a stable base pair, in vitro. We would also like to exclude that incorporation is due to a template-independent synthesis. In the presence of Mn 2+ no template-independent synthesis is observed using Klenow polymerase ( Figure 8 ). However, some template-independent synthesis is observed using Pol6G12 polymerase (although less than in the presence of the template).
Recognition of modified bases in vivo
In search for new orthogonal base pairs in vivo, it is important to know "if and how" the modified bases are functioning as template for canonical bases in vivo in the presence of cellular polymerases. To test the propagation of the XNA bases in vivo, the three bases were introduced separately (by chemical synthesis) in a sequence 5'-CTA GCG CCG TGC CAT GCA-3' representing the active site of thymidylate synthase (thyA) of E. coli (coding for Leu -Ala -Pro -Cys -His -Ala). They were introduced in the GCG codon (coding for Ala) and in the CCG codon (coding for Pro) (Table 6 ). These oligonucleotides were ligated enzymatically in a gapped vector, transformed in a strain of E. coli (lacking thyA) and living colonies were analyzed (ratio between bacterial colony numbers in ± thymidine (dT) media). Only in case a productive DNA polymerase ternary complex is obtained with the unnatural nucleotide and a tolerated amino acid substitution is coded by the targeted codon, living colonies are obtained (as thyA in an essential enzyme in E. coli). Sequencing gives us information as which canonical base the modified bases recognize and which amino acids are inserted in the active protein. In each case, 20 clones were picked out in the dT deficient media and sequenced.
As shown in Figure 9 , all three bases are very poorly recognized in vivo, when compared with the positive control. Even after introduction of only one base, the efficiency of transliteration of XNA to DNA is reduced to approximately 10 % in all cases. This percentage is further reduced between 0 % to 2 % when introducing two or three modified bases. When bars are not visible (Figure 9 ), only 1 or 2 colonies could be obtained, except for Y (2-methyl-6-thiopurine), inserted in GC() C()G, where no colony was obtained. These modified bases come close to the definition of orthogonal bases.
2-Amino-6-methyl-8-oxo-7,8-dihydro-purine, when introduced as third base in the Ala codon GCG (GCX) is recognized as a purine base (84 % as GCG and 16 % as GCA) ( Table 7 ). Both triplets code for the amino acid "Ala". When 2-amino-6-methyl-8-oxo-7,8-dihydro-purine base is introduced as first or second base in the Pro codon (XCG and CXG), it is always (100 %) recognized as a cytosine base (CCG and CCG), coding for Pro (Table 8 ). This could be explained by X is recognized by G in a WobbleHoogsteen type association. These data are obtained using ON 17 and ON 18 where X is also incorporated in the Ala codon which might give some bias for base incorporation, especially for XCG (ON 18) It should be mentioned that not only CCG (coding for Pro) but also TCG (coding for Ser), GCG (coding for Ala) and CGG (coding for Arg) are tolerated at this position of the ThyA gene. However, we cannot conclude on the real impact of the individual amino acid substitutions on the enzyme efficiency. This observation is of interest as it shows that selection pressure (invariably Ala-Pro is selected) in this case is higher than structural constrains. The modified base can behave either as a purine or either as a pyrimidine analogue in vivo dependent on the place where it is inserted in the gene. Needless to say that there is no correlation with the results obtained by thermal stability experiment of the modified oligonucleotides (see previous), where hybridization of 2-amino-6-methyl-8-oxo-7,8-dihydro-purine X with A,G,C,T is very poor, if existing at all, and similar for all 4 canonical bases. Clearly, E.coli DNA polymerases have a key role in the selection procedure via stabilization of the protein-dsDNAdNTP ternary complex. The 2-methyl-6-thiopurine base Y, when incorporated in the GCG (Ala) codon at the third position (GCY) is recognized almost exclusively (99 %) as a G (GCG) and in 1 % of the cases as a T (GCT) ( Table 7) . Both triplets code for Ala. When an extra modified base is introduced in the CCG (Pro) codon at the first position (YCG), it is recognized for 93 % as G base (GCG) coding for Ala and for 7 % as C base (CCG) coding for Pro (Table 8) . When 2-methyl-6-thiopurine base is incorporated in the second position of the same codon (CYG) it is recognized as a cytosine base (CCG) in 100 % of the cases (Table 8) . When introduced as well in the first as the second position (ON 23) of this CCG code (YYG), the codon only codes for Ala giving GCG as codon, and not anymore for Pro (data not shown in Table 8 ). It thus seems that the presence of one modified base in a codon may influence the recognition pattern of a second modified base, introduced in the same codon. Structural constrains seem more challenging than the selection pressure which leads to the high substitution of Pro by Ala (93 %). It should be remembered, of course, that only viable codons can be detected which is a bias of the analytical system (the obtained results are steered by the kind of amino acids that are accepted at a certain position in the protein). In the Ala codon (GCY), however, this does not make a difference as all four possible codons (GCA, GCT, GCC, GCG) lead to the incorporation of Ala at this site of the protein (still a bias may exist based on the preferential use of E. coli for certain codons). Finally, the 6-methyl-4-pyrimidone nucleoside Z was analysed in vivo, which gives a more complicated profile. In the Ala codon (GCZ), the 6-methyl-4-pyrimidone base is mainly recognized as a pyrimidine base (75 % as the T giving GCT, and 17 % as C giving GCC) and as G base to a minor extend (8 % as GCG) (Table 7) . When introduced in the first position of the CCG code (ZCG) we find equal amounts of the TCG code (Ser) and CCG code (Pro) which means that 6-methyl-4-pyrimidone behaves as a pyrimidine base and the Ser substitution is well tolerated in thymidylate synthase ( Table 8 ). The same amino acids (Ser and Pro) are coded for when the modified base is introduced at the first and second position (ZZG). When introduced only at the second position (CZG), the pyrimidone base is still recognized in majority as pyrimidine base (CCG), but also as G base in minority (CGG) coding for Arg. When three modified bases are introduced in a row (GCZ ZZG), 58 % of Ala-Ser is introduced (GCT TCG) and 42 % of Ala-Pro (17 % GCG CCG, 17 % GCC CCG, 8 % GCT CCG) (data not shown in Table 8 ).
It is difficult to make general statements about the preferred recognition of modified purine and modified pyrimidine bases at this moment. Shape recognition (purine-pyrimidine base pair formation) is, however, important. The Z base is recognized as a pyrimidine in 90% of the cases (and only in 8-10% as a purine).
Transversions coming from a purine-purine base pair are observed in relatively high yield with the X and Y base, probably because of the syn-anti equilibrium that may convert a purine to a pyrimidine-like base. Accepted Manuscript
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Conclusions
An efficient synthetic scheme was developed for the synthesis of the protected phosphoramidites of 2'-deoxynucleosides with a 2-amino-6-methyl-8-oxo-7,8-dihydro-purine (X), a 2-methyl-6-thiopurine (Y) and a 6-methyl-4-pyrimidone (Z) base moiety. These building blocks were successfully used for oligonucleotide synthesis. These modified bases do not form base pairs with itself (X:X and Y:Y) and with the natural bases (A, G, C, T). Substitution of a polar functional group (NH 2 , OH) of nucleobases by a methyl group at positions that are normally involved in H-bonding of canonical bases (the 6-carbonyl group of pyrimidine base, the 2-amino and 6-carbonyl group of purine base) readily leads to orthogonality (absence of base pairing with canonical bases). As demonstrated with the T H :G S base pair [16] base pairing between methylated bases or bases with a thiocarbonyl group might easier occur when a H-atom is present in the opposite base (Figure 1c) . However, the latter bases might not be really orthogonal. Surprisingly, some selected polymerases are still able to incorporate the 2-amino-6-methyl-8-oxo-7,8-dihydro-purine nucleoside opposite itself in a template. In vivo, 2-amino-6-methyl-8-oxo-7,8-dihydro-purine is mainly recognized as a A/G or C base. 2-Methyl-6-thio-purine is recognized as a G or C base (and in a minor case as T base). 6-Methyl-4-pyrimodone is in vivo mostly recognized as T, C but sometimes also as a G base. Although principles like shape recognition (purine-pyrimidine base pair formation) plays a role in the recognition process, it is not the only factor involved. The low efficiency of the transliteration process of XNA to DNA might implement some degree of randomness in the nucleotide selection procedure by the incorporated modified (XNA) nucleotide, when pyrimidine heterocycles (smaller heterocycles) are involved. 13 C NMR, 150 MHz) spectrometers. 2D NMRs (H-COSY, HSQC and HMBC) were used for the assignment of all the intermediates and final compounds. Mass spectra were acquired on a quadrupole orthogonal acceleration time-offlight mass spectrometer. Column chromatographic separations were carried out by gradient elution with suitable combination of two/three solvents and silica gel (100-200 mesh or 230-400 mesh). Solvents for reactions were distilled prior to use: THF and toluene from Na/benzophenone; CH2Cl2 and CH3CN from CaH2; Et3N and pyridine from KOH.
Experimental Section
2-Chloro-4,5-diamino-6-methyl pyrimidine (3)
. A solution of Na2S2O4 (28.67 g, 164.6 mmol) in water (78 mL) was added to the stirred solution of 2 (10.35 g, 54.9 mmol) in THF (274 mL) and ethyl acetate (78 mL) at room temperature and the reaction was stirred for 3 hours. Ethyl acetate (200 mL) was added and extracted. The extract was dried over Na2SO4 and concentrated in vacuo. The crude mixture was purified by column chromatography using DCM:MeOH (9:1, v/v) as solvent to afford 3 (3.42 g, 39%). Analytical data of compound 3 was found to be identical to the reported compound. [25] 2-Chloro-6-methyl-8-oxo-7,8-dihydro-purine (4).
1,1'-Carbonyl diimidazole (7.00 g, 43.2 mmol) was added to the solution of 2-chloro-4,5-diamine-6-methyl-pyrimidine 3 (3.42 g, 21.6 mmol) in 1,4-dioxane (10 mL) and stirred at 110 °C under nitrogen for 50 min. Solvents were evaporated to obtain a yellow oil and CH2Cl2 (150 mL) was added. The flask shaken vigorously and allowed to settle the precipitate overnight. Solids were filtered through sintered funnel, washed with CH2Cl2 and dried under vacuum at 45 °C to afford 4 (3.29, 83%). 1 H NMR (300 MHz, DMSO-d6) δ 12.00 (br s, 1H, NH), 11.39 (br s, 1H, NH), 2.37 (s, 3H, CH3). 
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20.4 mmol) and the mixture was stirred at room temperature under a nitrogen atmosphere for 30 min. 1-Chloro-2-deoxy-3,5-di-O-p-toluoyl-Derythro-pentofuranose (7.20 g, 18.5 mmol) was added portion wise with stirring. The reaction mixture was stirred at 50 °C for 3 h and filtered to remove a small amount of insoluble material. Evaporation of the filtrate gave an oily residue, which was purified by silica gel column chromatography using ethyl acetate (35%) in hexane to afford nucleoside α-and β-5 (3.00 g, 30% -6-methyl-8-oxo-7,8-dihydro-9-(2-deoxy-5 -O-dimethoxytrityl-β-D-erythro-pentofuranos-1-yl)-purine (7). Compound α-and β-6 (320 mg, 1.41 mmol) was co-evaporated with dry pyridine twice under argon atmosphere and then dissolved in dry pyridine (15 mL). 4,4'-Dimethoxytrityl chloride (527 mg, 1.56 mmol) in CH2Cl2 (2 mL) was slowly added drop wise under argon atmosphere at 0 °C, then the mixture was stirred at room temperature for 2 h. The reaction was quenched by the addition of MeOH and the solvents were evaporated. The residue was dissolved in CH2Cl2 and washed with H2O, the organic layers were dried on Na2SO4 and evaporated under argon atmosphere. The compound 7 was isolated as β anomer by column chromatography separation (CH2Cl2/MeOH/TEA 97:2:1) as a white foam (372 mg, 58%). 
2-Chloro
2-Chloro-6-methyl-8-oxo-7,8-dihydro-9-(2-deoxy-β-D-erythropentofuranos-1-yl)-purine (8).
Compound 7 (0.431 mmol, 0.26 g) was dissolved in a mixture of CH2Cl2 and MeOH (1:1 v/v, 25 mL), and HCl in MeOH (0.14 mL of 1.25 mol L -1 solution) was added portion wise. The reaction was monitored by TLC CH2Cl2/MeOH(95:5). Once completed, the reaction mixture was neutralized with pyridine (1 mL), and the liquid was concentrated. The resulting oil was purified by column chromatography CH2Cl2/MeOH (96:4) to afford 8 (54 mg 70%). 
2-N, N-dimethylformamidine-6-methyl-8-oxo-9-(2'-deoxy-α/β-Derythro-pentofuranos-1-yl)-purine 12:
To the solution of anomeric mixture of nucleoside 6 (1.05 gm, 3.49 mmol) in ethanol (10 mL) was added hydrazine (1.36 mL, 34.92 mmol, 80%). Reaction mixture was stirred at 84 °C for 12 hrs. The reaction mixture was concentrated and the crude unstable hydrazine derivative α-and β-9 was used for next reaction immediately. To an ice-cold solution of crude compound α-and β-9 (3.49 mmol) in acetic acid (23 mL) was added dropwise a solution of sodium nitrite (53.16 mol) in a least amount of water in an ice bath at −5 °C. The reaction mixture was allowed to stir at room temperature for 12 hrs and concentrated in vacuo to afford inseparable anomeric mixture of nucleoside α-and β-10. To the solution of crude nucleoside α-and β-10 (3.49 mmol) in methanol was added PtO2 (0.71 mmol) and reaction mixture was stirred under hydrogen atmosphere (1.38 bar) at 55 °C for 45 hrs. The reaction mixture was filtered through the celite and concentrated under vacuo to afford the anomeric mixture of 2-Amino-6-methyl-8-oxo-9-(2'-deoxy-D-ribofuranosyl)-purine α-and β-11 (X), HRMS (ESI+): calcd for C11H15N5O4 [ 
2-N,N-dimethylformamidino-6-methyl-8-oxo-7,8-dihydro-9-(2-deoxy-5-O-dimethoxy trityl-β-D-erythro-pentofuranos-1-yl)-purine (13).
Compound α-and β-12 (444 mg, 1.32 mmol) was co-evaporated with dry pyridine twice under argon atmosphere and then dissolved in dry pyridine (26 mL). 4,4'-Dimethoxytrityl chloride (447 mg, 1.35 mmol) in CH2Cl2 (2 mL) was slowly added drop wise under argon atmosphere at 0 °C, then the mixture was stirred at room temperature for 3 h. The reaction was quenched by the addition of MeOH and the solvents were evaporated. The residue was dissolved in CH2Cl2 and washed with H2O, the organic layers were dried on Na2SO4 and evaporated under argon atmosphere. The compound 13 was isolated as beta anomer by column chromatography (CH2Cl2/MeOH/Pyridine 96:3:1) as a white solid (360 mg, 43%). 
2-N, N-dimethylformamidine-6-methyl-8-oxo-9-(2'-deoxy-β-D-erythropentofuranos-1-yl)-purine (β-12):
The column of silica gel (10.0 g) was first prepared in dichloromethane containing 1% pyridine. This column was overlayed with a small buffer of sand followed by more silica gel (3.0 g) in dichloromethane containing 1% TFA. The compound 13 (100 mg) was then loaded in 3 mL of CH2Cl2. The column was eluted with gradient solvent system CH2Cl2/MeOH/Pyridine. The compound β-12 was eluted with CH2Cl2/MeOH/Pyridine (96:3:1). -6-methyl-8-oxo-7,8-dihydro 8-9-(2-deoxy-5-O-triphosphate-β-D-erythro-pento-furanos-1-yl-purine (15) . To an ice-cold solution of protected nucleoside β-12 (30 mg, 0.09 mmol) in trimethyl phosphate (TMP) (1.0 mL) was added phosphoryl chloride (12 µL, 0.13 mmol.) and the solution stirred at 0°C for 5 hours. Tributylamine (105 µL, 0.44 mmol) and tetrabutylammonium pyrophosphate solution (240 mg, 0.27 mmol) in DMF (1 mL) was added simultaneously, and the solution stirred for a further 30 minutes. The reaction was then quenched by the addition of 0.5 M triethylammonium bicarbonate (TEAB) buffer (10 mL), and stored at 4°C overnight. The solvent was evaporated and the residue was treated with 25% ammonia (1 mL) for 15 min. The solution was evaporated to dryness and re-dissolved in water (5 mL) and applied to a Sephadex A25 column in 0.1 M TEAB buffer. The column was eluted with a linear gradient of 0.1-1.0 M TEAB. Appropriate fractions were pooled and evaporated to dryness to give desired product. The final purification was performed by RP HPLC (Alltima 5µ C-18 reverse phase column, buffer A, 0.1 M TEAB; buffer B, 0.1 M TEAB, 50% MeCN. 0% to 100% buffer B over 60 min). 
2-Amino
6-Methyl-3-(2-deoxy-β-D-erythro-pentofuranos-1-yl)-4(3H)-pyrimidone (Z).
To a stirred solution of 6-methyl-4-pyrimidone (637 mg, 5.79 mmol) in acetonitrile (25 mL) at room temperature under argon was added bis(trimethylsilyl)acetamide (1.18 g, 5.79 mmol). After stirring at ambient temperature for 40 min, 1-chloro-2-deoxy-3,5-di-O-p-toluoyl-Derythro-pentofuranose (1.5 g, 3.86 mmol) and dropwise SnCl4 (3.87 mL, 3.86 mmol) was added. After 1 h, complete dissolution of the 2-deoxyribofuranoside had occurred. To the reaction was added EtOAc, and the resulting solution was successively extracted with saturated NaHCO3 and brine. The organics were dried over anhydrous Na2SO4, and solvents were removed in vacuo. Purification via flash column chromatography on silica gel (30-50% ethyl acetate in hexanes) afforded a mixture of two anomers. The anomeric mixture was treated with 5 M solution of sodium methoxide (0.650 mL) for 2 h at room temperature. The mixture was concentrated and the residue was purified by flash column chromatography (CH2Cl2/MeOH 8.5:1.5) to yield the title compound Z as a white solid (315 mg, 36 %). 1 H NMR (600 MHz, DMSO-d6) δ 8.63 (s, 1H, H2), 6.25 -6.11 (m, 2H, H5,H1'), 5.27 (d, J = 4.2 Hz, 1H, OH), 5.07 (t, J = 5.1 Hz, 1H, OH), 4.27 (dq, J = 7.5, 3.8 Hz, 1H, H3'), 3.87 (q, J = 3.6 Hz, 1H, H4'), 3.64 (ddd, J = 11.9, 5.0, 3.7 Hz, 1H, H5b'), 3.57 (ddd, J = 11.9, 4.7, 4.1 Hz, 1H, H5a'), 2.29 (ddd, J = 13.3, 6.2, 3.8 Hz, 1H, H2b'), 2.19 (s, 3H, CH3), 2.12 -2.08 (m, 1H, H2a'); 13 C NMR (151 MHz, DMSO-d6) δ l163.4 (C4), 159.9 (C6), 147.7 (C2), 111.3 (C5), 88.0 (C4'), 84.4 (C1'), 70.1 (C3'), 60.9 (C5'), 41.1 (C2'), 23 
2-Methyl-6-chloro-9-(2-deoxy-3,5-di-O-p-toluoyl-β-D-erythropentofuranos-1-yl)-purine (18a).
A mixture of 6-chloro-2-methylpurine [26] (520 mg, 3.09 mmol) and 60% sodium hydride (164 mg, 4.11 mmol) in anhydrous acetonitrile (15 mL) was stirred at ambient temperature for 30 minutes under a nitrogen atmosphere. The 1-chloro-2-deoxy-3,5-di-O-ptoluoyl-D-erythro-pentofuranose (800 mg, 2.06 mmol) was added portionwise, and stirred for 2 hours. The reaction mixture was diluted with ethylacetate and washed with water. The organics were dried over anhydrous Na2SO4, and solvents were removed in vacuo. Purification via column chromatography on silica gel (30% ethyl acetate in hexanes) afforded the desired product 18a as a white solid compound (815 mg, 76%). 
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This article is protected by copyright. All rights reserved. 2-Methyl-6-cyanoethylthio-9-(2-deoxy-β-D-erythro-pentofuranos-1-yl)-purine (19) . To a solution of dry compound Z (25 mg, 0.88 mmol) in dry DMF (6 mL) was added powdered anhydrous potassium carbonate (474 mg, 3.54 mmol). This was followed by the addition of 3-bromopropionitrile (367 mg, 2.66 mmol) via a dry syringe. After stirring at room temperature for 12 hours the DMF was removed by coevaporation with xylenes and the residue was purified by flash column chromatography (CH2Cl2/MeOH 95:5) to yield the title compound 19 as a white solid (240 mg, 80%). 
Oligonucleotide synthesis.
Oligonucleotide assembly was performed with an Expedite DNA synthesizer (Applied Biosystems) by using the phosphoramidite approach. The oligomers were deprotected and cleaved from the solid support by treatment with aqueous ammonia (30%) for 1/2 h at 25 °C and 1 h at 55 °C. After gel filtration on a NAP-25 column (Sephadex G25-DNA grade from GE Healthcare) with water as eluent, the crude mixture was analyzed by using a Mono-Q HR 5/5 anion exchange column, after which purification was achieved by using a Mono-Q HR 10/100 GL column (Pharmacia) with the following gradient system: Buffer A = 10 mM NaClO4 with 20 mM TrisHCl in 15% CH3CN, pH = 7,4. Buffer B = 600 mM NaClO4 with 20 mM TrisHCl in 15% CH3CN, pH=7,4. The low-pressure liquid chromatography system consisted of a HITACHI Primaide organizer with a HITACHI Primaide 1410 UV detector and with a HITACHI Primaide 1110 pump and a Mono-Q HR 10/100 GL column (Pharmacia). The product-containing fraction was desalted on a NAP-25 column and lyophilised, followed by analysis by mass spectrometry.
UV melting experiments.
Oligomers were dissolved in a buffer solution containing NaCl (0.1 M), KH2PO4 (0.02 M, pH 7,5) and EDTA (0.1 mM). The concentration was determined by measuring the absorbance in Milli-Q water at 260 nm at 80°C. The following extinction coefficients were used: dA, ε=15.060; dC, ε=7.100; dG, ε=12.180; dT, ε=8.560; X, ε= 2089; Y, ε = 903; Z, ε = 2919. Extinction coefficient have been determined at 260 nm, which is not the maximum of absorption, but the wavelength at which the concentration of the oligonucleotide is determined. The concentration for each strand was 4 µM in all experiments. Melting curves were determined with a Varian Cary 100 BIO spectrophotometer. Cuvettes were maintained at constant temperature by water circulation through the cuvette holder. The temperature of the solution was measured with a thermistor that was directly immersed in the cuvette. Temperature control and data acquisition were carried out automatically with an IBM-compatible computer by using Cary WinUV thermal application software. A quick heating and cooling cycle was carried out to allow proper annealing of both strands. The samples were then heated from 10 to 80 °C at a rate of 0.2 °C min-1, and were cooled again at the same speed. Melting temperatures were determined by plotting the first derivative of the absorbance as a function of temperature; data plotted were the average of two runs. Up and down curves showed identical Tm values.
Circular dichroism materials and methods.
For CD analysis, 4 µM of modified duplex [5'-d Primer extension experiments by DNA polymerases.
The incorporation of natural dNTPs and the 2-amino-6-Methyl-8-oxo-7,8-dihydro-purine nucleoside triphosphate was carried out using a Cy5 fluorescence labeled primer and a template containing one or three 2-amino-6-methyl-8-oxo-7,8-dihydro-purine nucleosides, incorporated (ON 28, 29). The primer 5'Cy5-CAGGAAACAGCTATGAC-3' was annealed with one of the templates 5'-AACTGXGTCATAGCTGTTTCCTG-3' or 5'-AACTGXXXGTCATAGCTGTTTCCTG-3' in a 1:2 molar ratio by heating the mixture at 95 °C for 5 minutes followed by slow cooling to room temperature. A mesophilic DNA polymerase: Klenow fragment exo-(New England Biolabs) and a thermostable polymerase Pol6G12 [27] were used. The final DNA polymerization mixtures each contained 125 nM primertemplate duplex, reaction buffer (NEBuffer 2 was used for Klenow fragment exo-and ThermoPol buffer was used for Pol6G12) and 50 µM of the natural dNTPs or 50 µM or 200 µM of 2-amino-6-Methyl-8-oxo-7,8-dihydro-purine nucleoside triphosphate. Final concentration in a reaction of Klenow fragment exo-and Pol6G12 were 0.0017 U/µl and 0.0186 U/µl, respectively. One millimolar of MnCl2 was added in the reaction as indicated. The reactions were performed at 37 °C for Klenow fragment exoand 75 °C for Pol6G12. Aliquotes were taken after 60 min and quenched by adding to a double volume of quenching buffer (90 % formamide, 50 mM EDTA, and 0.05 % bromophenol blue) and heated at 95 °C for 5 min. The samples were separated on a 1 mm 15 % denaturing polyacrylamide gel and gel bands were visualized using the Typhoon FLA 9500 phosphor imager (GE Healthcare Life Sciences). The images were processed using ImageQuant TL v8.1.0.0 (GE Healthcare).
In vivo transliteration and mutational analysis directed by modified oligonucleotides ligated to plasmid DNA.
Oligonucleotides were dissolved in milliQ water to 1 mM and diluted ten fold before assay. Oligonucleotides were tested inside a gapped heteroduplex generated through the enzymatic modification of two different plasmids pAK1 and pAK2. The form of the heteroduplex is described elsewhere in details (S. Pochet, C. R. Biologies, 2003 and Pezo, Angew. Chem., 2013). [3a, 3c] A mix of equimolar (25 ng each) purified NheI and NsiI cut pAK1 and purified EcoRI cut and dephosphorylated pAK2 were resuspended in 10 mM Tris-HCl pH 7.5 with 100 mM NaCl in 20 μL final volume. The mixture was denaturated at 95 °C for 5 min before cooling to ambient temperature over 2 h for hybridization, before water dialysis through 0.05 μM nitrocellulose filter (Millipore) for 30 min. The oligonucleotides (100 pmoles), as well as a positive control (olignucleotide with intact catalytic residue codon) and two negative controls (water and oligomer with deleted catalytic residue codon) were added separately to the dialyzed heteroduplex mixture in 1x DNA ligase T4 reaction buffer (NEB) for 20 μL per sample. The mixture was then denaturated at 85 °C and cooled as before. Ligation was performed by adding 1 mM ATP and 5 U T4 DNA ligase (NEB) to the samples before overnight incubation at 16 °C. Ligated mixtures were dialyzed as before, and transformed by electroporation into fresh electro-competent E. coli K12 strain (ΔthyA:aad). Incubation of the electroporated bacteria was performed at 37 °C for 1 hour, before plating 100 μL of a serial dilution of the suspension onto Muller-Hinton (MH) media containing 100 μg mL -1 ampicillin (spreading the 10 0 and 10 -1 dilutions) and onto the same media supplemented additionally with 0.3 mM thymidine (10 -3 and 10 -4 dilutions). 
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